Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 760679, 8 pages
http://dx.doi.org/10.1155/2012/760679
Research Article

Aberrant Expression of N-Methylpurine-DNA Glycosylase Influences Patient Survival in Malignant Gliomas

1Department of Neurosurgery, The 309th Hospital of PLA, Beijing 100091, China
2Department of Emergency, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China
3Administrative Department, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China
4Department of Neurosurgery, 254th Hospital of PLA, Tianjin 300142, China
5Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China

Received 27 November 2011; Revised 1 January 2012; Accepted 18 January 2012

Academic Editor: Paul W. Doetsch

Copyright © 2012 Ce Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Ohgaki and P. Kleihues, “Epidemiology and etiology of gliomas,” Acta Neuropathologica, vol. 109, no. 1, pp. 93–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, pp. 97–109, 2007. View at Google Scholar
  3. Y. G. Mu, M. Z. Chen, Z. P. Chen, W. N. Zhou, X. H. Zhang, and K. Sai, “Microsurgical technique of brain glioma—a report of 183 cases,” Ai Zheng, vol. 23, no. 11, pp. 1317–1321, 2004. View at Google Scholar · View at Scopus
  4. C. Y. Chang, M. C. Li, S. L. Liao, Y. L. Huang, C. C. Shen, and H. C. Pan, “Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.,” Journal of Clinical Neuroscience, vol. 12, no. 8, pp. 930–933, 2005. View at Google Scholar · View at Scopus
  5. E. R. Laws, I. F. Parney, W. Huang et al., “Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project,” Journal of Neurosurgery, vol. 99, no. 3, pp. 467–473, 2003. View at Google Scholar · View at Scopus
  6. H. Lin, Y. Wang, X. Zhang, B. Liu, W. Zhang, and J. Cheng, “Prognostic significance of kappaB-Ras1 expression in gliomas,” Medical Oncology. In press.
  7. S. Adhikari, S. Choudhury, P. S. Mitra, J. J. Dubash, S. P. Sajankila, and R. Roy, “Targeting base excision repair for chemosensitization,” Anti-Cancer Agents in Medicinal Chemistry, vol. 8, no. 4, pp. 351–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. N. Trivedi, X. H. Wang, E. Jelezcova, E. M. Goellner, J. B. Tang, and R. W. Sobol, “Human methyl purine DNA glycosylase and DNA polymerase β expression collectively predict sensitivity to temozolomide,” Molecular Pharmacology, vol. 74, no. 2, pp. 505–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. F. Harrison, M. L. Rinne, M. R. Kelley, N. M. Druzhyna, G. L. Wilson, and S. P. Ledoux, “Altering DNA base excision repair: use of nuclear and mitochondrial- targeted N-methylpurine DNA glycosylase to sensitize astroglia to chemotherapeutic agents,” Glia, vol. 55, no. 14, pp. 1416–1425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Kaina, G. Fritz, and T. Coquerelle, “Contribution of O6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: new insights gained from studies of genetically engineered mammalian cell lines,” Environmental and Molecular Mutagenesis, vol. 22, no. 4, pp. 283–292, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. S. K. Randall, R. Eritja, B. E. Kaplan, J. Petruska, and M. F. Goodman, “Nucleotide insertion kinetics opposite abasic lesions in DNA,” Journal of Biological Chemistry, vol. 262, no. 14, pp. 6864–6870, 1987. View at Google Scholar · View at Scopus
  12. M. L. Fishel, Y. R. Seo, M. L. Smith, and M. R. Kelley, “Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing,” Cancer Research, vol. 63, no. 3, pp. 608–615, 2003. View at Google Scholar · View at Scopus
  13. S. R. Cerda, P. W. Turk, A. D. Thor, and S. A. Weitzman, “Altered expression of the DNA repair- protein, N-methylpurine-DNA glycosylase (MPG), in breast cancer,” The FEBS Letters, vol. 431, no. 1, pp. 12–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. T. J. Sohn, N. K. Kim, H. J. An et al., “Gene amplification and expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in HPV-infected cervical neoplasias,” Anticancer Research, vol. 21, no. 4, pp. 2405–2411, 2001. View at Google Scholar · View at Scopus
  15. M. L. Fishel, Y. He, M. L. Smith, and M. R. Kelley, “Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide,” Clinical Cancer Research, vol. 13, no. 1, pp. 260–267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Wang, Z. Y. Zhong, Q. H. Zhang, Z. P. Li, and M. R. Kelley, “Effect of adenoviral N-methylpurine DNA glycosylase overexpression on chemosensitivity of human osteosarcoma cells,” Chinese Journal of Pathology, vol. 35, no. 6, pp. 352–356, 2006. View at Google Scholar · View at Scopus
  17. M. Rinne, D. Caldwell, and M. R. Kelly, “Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells,” Molecular Cancer Therapeutics, vol. 3, no. 8, pp. 955–967, 2004. View at Google Scholar · View at Scopus
  18. N. K. Kim, J. Y. Ahn, J. Song et al., “Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors,” Anticancer Research, vol. 23, no. 2, pp. 1417–1423, 2003. View at Google Scholar · View at Scopus
  19. J.-B. Tang, D. Svilar, R. N. Trivedi et al., “N-methylpurine DNA glycosylase and DNA polymerase β modulate BER inhibitor potentiation of glioma cells to temozolomide,” Neuro-Oncology, vol. 13, no. 5, pp. 471–486, 2011. View at Publisher · View at Google Scholar
  20. M. M. Bradford, “Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar
  21. N. K. Kim, H. J. An, H. J. Kim et al., “Altered expression of the DNA repair protein, N-methylpurine-DNA glycosylase (MPG) in human gonads,” Anticancer Research, vol. 22, no. 2, pp. 793–798, 2002. View at Google Scholar · View at Scopus
  22. M. L. Rinne, Y. He, B. F. Pachkowski, J. Nakamura, and M. R. Kelley, “N-methylpurine DNA glycosylase overexpression increases alkylation sensitivity by rapidly removing non-toxic 7-methylguanine adducts,” Nucleic Acids Research, vol. 33, no. 9, pp. 2859–2867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. N. K. Kim, S. H. Lee, K. Y. Cha, and J. S. Seo, “Tissue-specific expression and activation of N-methylpurine-DNA glycosylase in thymic carcinomas of transgenic mice expressing the SV40 large T-antigen gene,” Molecules and Cells, vol. 8, no. 4, pp. 383–387, 1998. View at Google Scholar · View at Scopus
  24. N. K. Kim, S. H. Lee, T. J. Sohn et al., “Spatial expression of a DNA repair gene, N-methylpurine-DNA glycosylase (MPG) during development in mice,” Anticancer Research, vol. 20, no. 5, pp. 3037–3043, 2000. View at Google Scholar · View at Scopus